EYEGATE PHARMACEUTICALS INC - COM (EYEG)

CUSIP: 30233M107

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
1,568,779
Share change
-212,395
Total reported value
$597,000
Price per share
$0.38
Number of holders
15
Value change
-$149,622
Number of buys
8
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q1 2018

As of 31 Mar 2018, EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,568,779 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, BARCLAYS PLC, US BANCORP \DE\, Bank of New York Mellon Corp, CREDIT SUISSE AG/, WEDBUSH SECURITIES INC, ACADIAN ASSET MANAGEMENT LLC, and NORTHERN TRUST CORP. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.